Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why AbCellera Biologics Stock Gained 10.6% Last Month

TheMotleyFool

0 0

Here's Why AbCellera Biologics Stock Gained 10.6% Last Month

Shares of AbCellera Biologics (NASDAQ: ABCL) climbed 10.6% in June, according to data from S&P Global Market Intelligence. The biotech company published its second-quarter earnings release on Aug. 12 and held a conference call to discuss its results and outlook, and the market liked what it heard.